Longboard Pharmaceuticals Ownership 2024 | Who Owns Longboard Pharmaceuticals Now?
Institutional Ownership
170.33%
Insider Ownership
1.09%
Retail Ownership
-71.42%
Institutional Holders
107.00
Longboard Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 24.20% | 0.57% | 5,790,500 | 4,230,000 | 271.07% | 125,074,800 | Mar 31, 2024 |
| FMR LLC | 18.91% | 0.01% | 4,525,070 | 2,875,567 | 174.33% | 97,741,512 | Mar 31, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 14.02% | 3.18% | 3,353,141 | 1,000,000 | 42.50% | 72,427,846 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 13.75% | 0.10% | 3,289,119 | 3,289,119 | 100.00% | 71,044,970 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 9.27% | 0.01% | 2,217,995 | 591,013 | 36.33% | 47,910,000 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 8.93% | 0.01% | 2,136,363 | 2,136,363 | 100.00% | 46,145,442 | Mar 31, 2024 |
| BLACKROCK INC. | 7.80% | 0.00% | 1,866,290 | 996,411 | 114.55% | 40,311,864 | Mar 31, 2024 |
| VANGUARD GROUP INC | 7.21% | 0.00% | 1,724,431 | 937,998 | 119.27% | 37,247,710 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 5.75% | 0.07% | 1,375,000 | 550,000 | 66.67% | 29,700,000 | Mar 31, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 5.46% | 0.15% | 1,305,431 | 305,431 | 30.54% | 28,197,310 | Mar 31, 2024 |
| VIKING GLOBAL INVESTORS LP | 4.10% | 0.08% | 981,328 | 981,328 | 100.00% | 21,196,685 | Mar 31, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 4.08% | 1.95% | 975,000 | 75,000 | 8.33% | 21,060,000 | Mar 31, 2024 |
| JENNISON ASSOCIATES LLC | 3.94% | 0.01% | 942,404 | 461,576 | 96.00% | 20,355,925 | Mar 31, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 2.90% | 1.84% | 693,144 | 263,252 | 61.24% | 14,971,910 | Mar 31, 2024 |
| STATE STREET CORP | 2.71% | 0.00% | 648,509 | 350,042 | 117.28% | 14,007,794 | Mar 31, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.41% | 0.01% | 576,676 | 576,676 | 100.00% | 12,456,202 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 2.37% | 0.02% | 566,498 | 566,498 | 100.00% | 12,236,356 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.32% | 0.00% | 556,083 | 221,422 | 66.16% | 12,012,893 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 2.23% | 0.00% | 533,035 | 533,035 | 100.00% | 11,513,556 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 2.11% | 0.00% | 505,174 | -29,542 | -5.52% | 10,911,759 | Mar 31, 2024 |
Longboard Pharmaceuticals's largest institutional shareholder is FARALLON CAPITAL MANAGEMENT LLC, holding 24.20% of the company's total share outstanding, currently valued at $125.07M. The top 10 institutional shareholders own together 115.29% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALLY BRIDGE GROUP (NY) LLC | 1.13% | 3.25% | 270,559 | 270,559 | 100.00% | 5,844,074 | Mar 31, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 14.02% | 3.18% | 3,353,141 | 1,000,000 | 42.50% | 72,427,846 | Mar 31, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 0.49% | 2.37% | 118,255 | 118,255 | 100.00% | 2,554,308 | Mar 31, 2024 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 4.08% | 1.95% | 975,000 | 75,000 | 8.33% | 21,060,000 | Mar 31, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 2.90% | 1.84% | 693,144 | 263,252 | 61.24% | 14,971,910 | Mar 31, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.71% | 1.45% | 170,000 | 170,000 | 100.00% | 3,672,000 | Mar 31, 2024 |
| AWM INVESTMENT COMPANY, INC. | 0.88% | 0.60% | 211,518 | 211,518 | 100.00% | 4,568,789 | Mar 31, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 24.20% | 0.57% | 5,790,500 | 4,230,000 | 271.07% | 125,074,800 | Mar 31, 2024 |
| EAM INVESTORS, LLC | 0.65% | 0.53% | 156,565 | 156,565 | 100.00% | 3,381,804 | Mar 31, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.42% | 0.26% | 100,000 | 100,000 | 100.00% | 2,160,000 | Mar 31, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 5.46% | 0.15% | 1,305,431 | 305,431 | 30.54% | 28,197,310 | Mar 31, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.53% | 0.11% | 127,048 | - | - | 2,744,237 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 13.75% | 0.10% | 3,289,119 | 3,289,119 | 100.00% | 71,044,970 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.62% | 0.08% | 388,472 | 388,472 | 100.00% | 8,390,995 | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.23% | 0.08% | 54,053 | -69,153 | -56.13% | 1,167,545 | Mar 31, 2024 |
| J. GOLDMAN & CO LP | 0.48% | 0.08% | 115,480 | 115,480 | 100.00% | 2,494,368 | Mar 31, 2024 |
| VIKING GLOBAL INVESTORS LP | 4.10% | 0.08% | 981,328 | 981,328 | 100.00% | 21,196,685 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 5.75% | 0.07% | 1,375,000 | 550,000 | 66.67% | 29,700,000 | Mar 31, 2024 |
| DENALI ADVISORS LLC | 0.04% | 0.06% | 9,300 | 9,300 | 100.00% | 200,880 | Mar 31, 2024 |
| SHAY CAPITAL LLC | 0.06% | 0.05% | 15,000 | 15,000 | 100.00% | 324,000 | Mar 31, 2024 |
The largest Longboard Pharmaceuticals shareholder by % of total assets is ALLY BRIDGE GROUP (NY) LLC. The company owns 270.56K shares of Longboard Pharmaceuticals (LBPH), representing 3.25% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 24.20% | 0.57% | 5,790,500 | 4,230,000 | 271.07% | 125,074,800 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 13.75% | 0.10% | 3,289,119 | 3,289,119 | 100.00% | 71,044,970 | Mar 31, 2024 |
| FMR LLC | 18.91% | 0.01% | 4,525,070 | 2,875,567 | 174.33% | 97,741,512 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 8.93% | 0.01% | 2,136,363 | 2,136,363 | 100.00% | 46,145,442 | Mar 31, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 14.02% | 3.18% | 3,353,141 | 1,000,000 | 42.50% | 72,427,846 | Mar 31, 2024 |
| BLACKROCK INC. | 7.80% | 0.00% | 1,866,290 | 996,411 | 114.55% | 40,311,864 | Mar 31, 2024 |
| VIKING GLOBAL INVESTORS LP | 4.10% | 0.08% | 981,328 | 981,328 | 100.00% | 21,196,685 | Mar 31, 2024 |
| VANGUARD GROUP INC | 7.21% | 0.00% | 1,724,431 | 937,998 | 119.27% | 37,247,710 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 9.27% | 0.01% | 2,217,995 | 591,013 | 36.33% | 47,910,000 | Mar 31, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.41% | 0.01% | 576,676 | 576,676 | 100.00% | 12,456,202 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 2.37% | 0.02% | 566,498 | 566,498 | 100.00% | 12,236,356 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 5.75% | 0.07% | 1,375,000 | 550,000 | 66.67% | 29,700,000 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 2.23% | 0.00% | 533,035 | 533,035 | 100.00% | 11,513,556 | Mar 31, 2024 |
| LORD, ABBETT & CO. LLC | 1.99% | 0.03% | 475,179 | 475,179 | 100.00% | 10,264,000 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 2.01% | 0.00% | 479,809 | 466,110 | 3402.51% | 10,363,874 | Mar 31, 2024 |
| JENNISON ASSOCIATES LLC | 3.94% | 0.01% | 942,404 | 461,576 | 96.00% | 20,355,925 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.62% | 0.08% | 388,472 | 388,472 | 100.00% | 8,390,995 | Mar 31, 2024 |
| STATE STREET CORP | 2.71% | 0.00% | 648,509 | 350,042 | 117.28% | 14,007,794 | Mar 31, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 5.46% | 0.15% | 1,305,431 | 305,431 | 30.54% | 28,197,310 | Mar 31, 2024 |
| AMERICAN CENTURY COMPANIES INC | 1.17% | 0.00% | 279,926 | 279,926 | 100.00% | 6,046,402 | Mar 31, 2024 |
As of Mar 31 2024, Longboard Pharmaceuticals's largest institutional buyer is FARALLON CAPITAL MANAGEMENT LLC. The company purchased 4.23M stocks of LBPH, valued at $125.07M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 0.00% | 0.00% | 236 | -979,226 | -99.98% | 5,098 | Mar 31, 2024 |
| ENSIGN PEAK ADVISORS, INC | - | - | - | -301,161 | -100.00% | - | Mar 31, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -231,471 | -100.00% | - | Mar 31, 2024 |
| UBS OCONNOR LLC | 0.23% | 0.08% | 54,053 | -69,153 | -56.13% | 1,167,545 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 2.11% | 0.00% | 505,174 | -29,542 | -5.52% | 10,911,759 | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.08% | 0.00% | 19,974 | -12,773 | -39.01% | 431,438 | Mar 31, 2024 |
| BOURGEON CAPITAL MANAGEMENT LLC | - | - | - | -7,000 | -100.00% | - | Mar 31, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 569 | -4,603 | -89.00% | 12,000 | Mar 31, 2024 |
| STRS OHIO | - | - | - | -3,200 | -100.00% | - | Mar 31, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.04% | 0.00% | 9,976 | -2,057 | -17.09% | 215,000 | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | 0.00% | 127 | -1,529 | -92.33% | 2,743 | Mar 31, 2024 |
| AMALGAMATED BANK | 0.00% | 0.00% | 841 | -811 | -49.09% | 18,000 | Mar 31, 2024 |
| PLATINUM INVESTMENT MANAGEMENT LTD | 0.53% | 0.11% | 127,048 | - | - | 2,744,237 | Mar 31, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.29% | 0.03% | 70,000 | - | - | 1,512,000 | Mar 31, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.10% | 0.00% | 23,853 | - | - | 515,225 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 2 | 2 | 100.00% | 43 | Mar 31, 2024 |
| NISA INVESTMENT ADVISORS, LLC | - | - | 8 | 8 | 100.00% | 173,000 | Mar 31, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 20 | 20 | 100.00% | 432 | Mar 31, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 40 | 40 | 100.00% | 864,000 | Mar 31, 2024 |
| GAMMA INVESTING LLC | 0.00% | 0.00% | 72 | 72 | 100.00% | 1,555 | Mar 31, 2024 |
As of Mar 31 2024, Longboard Pharmaceuticals's biggest institutional seller is IKARIAN CAPITAL, LLC. The company sold -0.98M shares of LBPH, valued at $5.10K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 13.75% | 0.10% | 3,289,119 | 3,289,119 | 100.00% | 71,044,970 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 8.93% | 0.01% | 2,136,363 | 2,136,363 | 100.00% | 46,145,442 | Mar 31, 2024 |
| VIKING GLOBAL INVESTORS LP | 4.10% | 0.08% | 981,328 | 981,328 | 100.00% | 21,196,685 | Mar 31, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.41% | 0.01% | 576,676 | 576,676 | 100.00% | 12,456,202 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 2.37% | 0.02% | 566,498 | 566,498 | 100.00% | 12,236,356 | Mar 31, 2024 |
| LORD, ABBETT & CO. LLC | 1.99% | 0.03% | 475,179 | 475,179 | 100.00% | 10,264,000 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.62% | 0.08% | 388,472 | 388,472 | 100.00% | 8,390,995 | Mar 31, 2024 |
| AMERICAN CENTURY COMPANIES INC | 1.17% | 0.00% | 279,926 | 279,926 | 100.00% | 6,046,402 | Mar 31, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 1.13% | 3.25% | 270,559 | 270,559 | 100.00% | 5,844,074 | Mar 31, 2024 |
| AWM INVESTMENT COMPANY, INC. | 0.88% | 0.60% | 211,518 | 211,518 | 100.00% | 4,568,789 | Mar 31, 2024 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.79% | 0.03% | 187,879 | 187,879 | 100.00% | 4,058,186 | Mar 31, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 0.71% | 1.45% | 170,000 | 170,000 | 100.00% | 3,672,000 | Mar 31, 2024 |
| EAM INVESTORS, LLC | 0.65% | 0.53% | 156,565 | 156,565 | 100.00% | 3,381,804 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.62% | 0.00% | 147,323 | 147,323 | 100.00% | 3,182,177 | Mar 31, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 0.49% | 2.37% | 118,255 | 118,255 | 100.00% | 2,554,308 | Mar 31, 2024 |
| J. GOLDMAN & CO LP | 0.48% | 0.08% | 115,480 | 115,480 | 100.00% | 2,494,368 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.45% | 0.01% | 106,885 | 106,885 | 100.00% | 2,308,716 | Mar 31, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.42% | 0.26% | 100,000 | 100,000 | 100.00% | 2,160,000 | Mar 31, 2024 |
| PRUDENTIAL FINANCIAL INC | 0.34% | 0.00% | 80,350 | 80,350 | 100.00% | 1,735,560 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.30% | 0.00% | 71,400 | 71,400 | 100.00% | 1,542,000 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.21% | 0.00% | 50,900 | 50,900 | 100.00% | 1,099,440 | Mar 31, 2024 |
| SWISS NATIONAL BANK | 0.18% | 0.00% | 42,300 | 42,300 | 100.00% | 913,680 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.17% | 0.01% | 41,169 | 41,169 | 100.00% | 889,000 | Mar 31, 2024 |
| JUMP FINANCIAL, LLC | 0.16% | 0.02% | 38,034 | 38,034 | 100.00% | 821,534 | Mar 31, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.15% | 0.00% | 35,576 | 35,576 | 100.00% | 768,442 | Mar 31, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.14% | 0.00% | 33,710 | 33,710 | 100.00% | 728,008,000 | Mar 31, 2024 |
| TREXQUANT INVESTMENT LP | 0.11% | 0.01% | 25,501 | 25,501 | 100.00% | 550,822 | Mar 31, 2024 |
| CREDIT SUISSE AG/ | 0.10% | 0.00% | 25,034 | 25,034 | 100.00% | 540,734 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.10% | 0.00% | 22,949 | 22,949 | 100.00% | 495,701 | Mar 31, 2024 |
| SEI INVESTMENTS CO | 0.08% | 0.00% | 19,861 | 19,861 | 100.00% | 429,004 | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.08% | 0.03% | 19,110 | 19,110 | 100.00% | 413,000 | Mar 31, 2024 |
| JANE STREET GROUP, LLC | 0.08% | 0.00% | 18,538 | 18,538 | 100.00% | 400,421 | Mar 31, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.07% | 0.00% | 15,808 | 15,808 | 100.00% | 341,453 | Mar 31, 2024 |
| SHAY CAPITAL LLC | 0.06% | 0.05% | 15,000 | 15,000 | 100.00% | 324,000 | Mar 31, 2024 |
| QUANTBOT TECHNOLOGIES LP | 0.06% | 0.02% | 14,355 | 14,355 | 100.00% | 310,068 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.06% | 0.00% | 13,900 | 13,900 | 100.00% | 300,240 | Mar 31, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.06% | 0.00% | 13,196 | 13,196 | 100.00% | 285,034 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.05% | - | 11,349 | 11,349 | 100.00% | 245,138 | Mar 31, 2024 |
| DEUTSCHE BANK AG\ | 0.05% | 0.00% | 11,218 | 11,218 | 100.00% | 242,309 | Mar 31, 2024 |
| SQUAREPOINT OPS LLC | 0.04% | 0.00% | 10,712 | 10,712 | 100.00% | 231,379 | Mar 31, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.04% | 0.00% | 9,624 | 9,624 | 100.00% | 207,878 | Mar 31, 2024 |
| AMERIPRISE FINANCIAL INC | 0.04% | 0.00% | 9,515 | 9,515 | 100.00% | 205,524 | Mar 31, 2024 |
| INVESCO LTD. | 0.04% | - | 9,372 | 9,372 | 100.00% | 202,436 | Mar 31, 2024 |
| DENALI ADVISORS LLC | 0.04% | 0.06% | 9,300 | 9,300 | 100.00% | 200,880 | Mar 31, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.04% | 0.00% | 9,290 | 9,290 | 100.00% | 200,664 | Mar 31, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.03% | 0.00% | 6,102 | 6,102 | 100.00% | 132,000 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.02% | - | 5,600 | 5,600 | 100.00% | 120,960 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.01% | - | 2,400 | 2,400 | 100.00% | 51,840 | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | 0.01% | - | 1,689 | 1,689 | 100.00% | 36,000 | Mar 31, 2024 |
| 0.01% | 0.00% | 1,569 | 1,569 | 100.00% | 33,888 | Mar 31, 2024 | |
| METROPOLITAN LIFE INSURANCE CO/NY | 0.01% | 0.00% | 1,358 | 1,358 | 100.00% | 29,333 | Mar 31, 2024 |
| LIFESTEPS FINANCIAL, INC. | 0.00% | 0.00% | 200 | 200 | 100.00% | 4,320 | Mar 31, 2024 |
| GAMMA INVESTING LLC | 0.00% | 0.00% | 72 | 72 | 100.00% | 1,555 | Mar 31, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 40 | 40 | 100.00% | 864,000 | Mar 31, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 20 | 20 | 100.00% | 432 | Mar 31, 2024 |
| NISA INVESTMENT ADVISORS, LLC | - | - | 8 | 8 | 100.00% | 173,000 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 2 | 2 | 100.00% | 43 | Mar 31, 2024 |
Longboard Pharmaceuticals's largest new institutional shareholder by number of shares is RA CAPITAL MANAGEMENT, L.P., purchased 3.29M shares, valued at $71.04M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ENSIGN PEAK ADVISORS, INC | - | - | - | -301,161 | -100.00% | - | Mar 31, 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -231,471 | -100.00% | - | Mar 31, 2024 |
| BOURGEON CAPITAL MANAGEMENT LLC | - | - | - | -7,000 | -100.00% | - | Mar 31, 2024 |
| STRS OHIO | - | - | - | -3,200 | -100.00% | - | Mar 31, 2024 |
Longboard Pharmaceuticals's largest sold out institutional shareholder by shares sold is ENSIGN PEAK ADVISORS, INC, sold -0.30M shares, valued at -, as of undefined.
Longboard Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| PRUDENTIAL SECTOR FUNDS, INC. | 0.16% | 338,184 | 338,184 | - | Feb 29, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.11% | 544,951 | -141,171 | -20.58% | Dec 31, 2023 |
| T. Rowe Price New Horizons Fund, Inc. | 0.05% | 763,196 | -2,439 | -0.32% | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.04% | 339,270 | -232,257 | -40.64% | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.03% | 70,000 | 20,000 | 40.00% | Dec 29, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.03% | 1,778,489 | 1,229,175 | 223.77% | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 13,099 | - | - | Dec 31, 2023 |
| LORD ABBETT SECURITIES TRUST | 0.03% | 123,072 | 123,072 | - | Jan 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.02% | 229,738 | 229,738 | - | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.02% | 25,781 | -6,300 | -19.64% | Dec 31, 2023 |
| FIDELITY CAPITAL TRUST | 0.02% | 165,700 | 165,700 | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 2,430 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 24,357 | - | - | Dec 31, 2023 |
| FIDELITY SECURITIES FUND | 0.00% | 321,600 | 101,486 | 46.11% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 897,603 | 221,401 | 32.74% | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 244,122 | 83,922 | 52.39% | Feb 29, 2024 |
| AdvisorShares Trust | 0.00% | 3,045 | - | - | Dec 29, 2023 |
| Voya INVESTORS TRUST | 0.00% | 48,721 | -2,247 | -4.41% | Dec 31, 2023 |
| SEASONS SERIES TRUST | 0.00% | 15,702 | -556 | -3.42% | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 16,186 | - | - | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 1,286 | - | - | Dec 31, 2023 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 35,800 | 35,800 | - | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 12,995 | 12,995 | - | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 6,472 | - | - | Dec 31, 2023 |
| RBB FUND, INC. | 0.00% | 14,027 | 14,027 | - | Feb 29, 2024 |
| AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC | 0.00% | 2,011 | 2,011 | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 349 | - | - | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 543 | - | - | Dec 31, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 2,793 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 27,637 | 27,637 | - | Feb 29, 2024 |
| BlackRock ETF Trust | 0.00% | 58 | 58 | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 7,420 | 2,402 | 47.87% | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 4,800 | - | - | Dec 31, 2023 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 767 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 564,718 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 68,423 | 8,046 | 13.33% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 142 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 36,238 | -348 | -0.95% | Dec 31, 2023 |
| ProFunds | 0.00% | 222 | 92 | 70.77% | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 52,376 | 775 | 1.50% | Dec 31, 2023 |
| HARTFORD MUTUAL FUNDS INC/CT | 0.00% | 193,590 | 193,590 | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 600 | - | - | Dec 29, 2023 |
| ALLSPRING MASTER TRUST | 0.00% | 1,371 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 5,978 | -24 | -0.40% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 2,507 | - | - | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 70 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 17,304 | -3,513 | -16.88% | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 2,158 | - | - | Dec 31, 2023 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 3,860 | 3,860 | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 5,660 | 3,929 | 226.98% | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 2,282 | 274 | 13.65% | Feb 29, 2024 |
| Columbia Funds Series Trust II | 0.00% | 2,999 | 2,999 | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 9 | - | - | Dec 31, 2023 |
| NORTHERN FUNDS | 0.00% | 6,718 | - | - | Dec 29, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 689 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 40,431 | 40,215 | 18618.06% | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 12,371 | - | - | Dec 31, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,765 | -7 | -0.40% | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 3,060 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 5,681 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 5,417 | - | - | Dec 31, 2023 |
| John Hancock Funds II | 0.00% | 17,782 | 5,151 | 40.78% | Feb 29, 2024 |
| T. Rowe Price Multi-Strategy Total Return Fund, Inc. | 0.00% | 134 | 134 | - | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 15,109 | 15,109 | - | Feb 29, 2024 |
| Bridge Builder Trust | 0.00% | 4,439 | - | - | Dec 31, 2023 |
| GMO TRUST | 0.00% | 838 | 838 | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,801 | - | - | Dec 31, 2023 |
Longboard Pharmaceuticals's largest mutual fund holder by % of total assets is "PRUDENTIAL SECTOR FUNDS, INC.", owning 338.18K shares, compromising 0.16% of its total assets.
Longboard Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 107 | 105.77% |
| 31 Dec, 23 | 52 | 1.96% |
| 30 Sep, 23 | 51 | 2.00% |
| 30 Jun, 23 | 50 | 100.00% |
| 31 Mar, 23 | 25 | 38.89% |
| 31 Dec, 22 | 18 | 12.50% |
| 30 Sep, 22 | 16 | -5.88% |
| 30 Jun, 22 | 17 | -10.53% |
| 31 Mar, 22 | 19 | - |
| 31 Dec, 21 | 19 | - |
| 30 Sep, 21 | 19 | 26.67% |
| 30 Jun, 21 | 15 | -31.82% |
| 31 Mar, 21 | 22 | - |
As of 31 Mar 24, 107 institutions are holding Longboard Pharmaceuticals's shares, representing an increase of 105.77% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 40,751,250 | 146.56% |
| 31 Dec, 23 | 16,527,897 | 5.54% |
| 30 Sep, 23 | 15,660,436 | 7.73% |
| 30 Jun, 23 | 14,536,384 | 10.21% |
| 31 Mar, 23 | 13,190,232 | 81.35% |
| 31 Dec, 22 | 7,273,280 | 0.18% |
| 30 Sep, 22 | 7,260,149 | -3.71% |
| 30 Jun, 22 | 7,539,610 | -0.99% |
| 31 Mar, 22 | 7,614,710 | -2.15% |
| 31 Dec, 21 | 7,782,202 | 1.45% |
| 30 Sep, 21 | 7,670,788 | -3.83% |
| 30 Jun, 21 | 7,976,370 | -10.41% |
| 31 Mar, 21 | 8,903,335 | - |
Longboard Pharmaceuticals (LBPH) has 40.75M shares outstanding as of 31 Mar 24, up 146.56% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 170.33% | 3.44% |
| 31 Dec, 23 | 70.37% | 1.51% |
| 30 Sep, 23 | 68.18% | 1.34% |
| 30 Jun, 23 | 71.22% | 1.71% |
| 31 Mar, 23 | 64.63% | 3.59% |
| 31 Dec, 22 | 42.41% | 2.37% |
| 30 Sep, 22 | 42.27% | 2.18% |
| 30 Jun, 22 | 44.01% | 2.22% |
| 31 Mar, 22 | 44.57% | 1.53% |
| 31 Dec, 21 | 54.00% | 2.61% |
| 30 Sep, 21 | 45.48% | 2.02% |
| 30 Jun, 21 | 47.40% | 1.69% |
| 31 Mar, 21 | 52.91% | - |
As of 31 Mar 24, Longboard Pharmaceuticals is held by 170.33% institutional shareholders, representing a 3.44% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 92 | 206.67% |
| 31 Dec, 23 | 30 | 25.00% |
| 30 Sep, 23 | 24 | -41.46% |
| 30 Jun, 23 | 41 | 86.36% |
| 31 Mar, 23 | 22 | 120.00% |
| 31 Dec, 22 | 10 | 150.00% |
| 30 Sep, 22 | 4 | - |
| 30 Jun, 22 | 4 | -20.00% |
| 31 Mar, 22 | 5 | -16.67% |
| 31 Dec, 21 | 6 | -33.33% |
| 30 Sep, 21 | 9 | 50.00% |
| 30 Jun, 21 | 6 | -72.73% |
| 31 Mar, 21 | 22 | - |
92 institutional shareholders have increased their position in LBPH stock as of 31 Mar 24 compared to 30 in the previous quarter (a 206.67% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 8 | -20.00% |
| 31 Dec, 23 | 10 | -28.57% |
| 30 Sep, 23 | 14 | 133.33% |
| 30 Jun, 23 | 6 | 200.00% |
| 31 Mar, 23 | 2 | -50.00% |
| 31 Dec, 22 | 4 | -42.86% |
| 30 Sep, 22 | 7 | - |
| 30 Jun, 22 | 7 | 40.00% |
| 31 Mar, 22 | 5 | 25.00% |
| 31 Dec, 21 | 4 | -33.33% |
| 30 Sep, 21 | 6 | - |
| 30 Jun, 21 | 6 | - |
| 31 Mar, 21 | - | - |
8 institutional shareholders have reduced their position in LBPH stock as of 31 Mar 24 compared to 10 in the previous quarter (a -20.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 107 | 105.77% | 40,751,250 | 146.56% | 170.33% | 3.44% | 92 | 206.67% | 8 | -20.00% |
| 31 Dec, 23 | 52 | 1.96% | 16,527,897 | 5.54% | 70.37% | 1.51% | 30 | 25.00% | 10 | -28.57% |
| 30 Sep, 23 | 51 | 2.00% | 15,660,436 | 7.73% | 68.18% | 1.34% | 24 | -41.46% | 14 | 133.33% |
| 30 Jun, 23 | 50 | 100.00% | 14,536,384 | 10.21% | 71.22% | 1.71% | 41 | 86.36% | 6 | 200.00% |
| 31 Mar, 23 | 25 | 38.89% | 13,190,232 | 81.35% | 64.63% | 3.59% | 22 | 120.00% | 2 | -50.00% |
| 31 Dec, 22 | 18 | 12.50% | 7,273,280 | 0.18% | 42.41% | 2.37% | 10 | 150.00% | 4 | -42.86% |
| 30 Sep, 22 | 16 | -5.88% | 7,260,149 | -3.71% | 42.27% | 2.18% | 4 | - | 7 | - |
| 30 Jun, 22 | 17 | -10.53% | 7,539,610 | -0.99% | 44.01% | 2.22% | 4 | -20.00% | 7 | 40.00% |
| 31 Mar, 22 | 19 | - | 7,614,710 | -2.15% | 44.57% | 1.53% | 5 | -16.67% | 5 | 25.00% |
| 31 Dec, 21 | 19 | - | 7,782,202 | 1.45% | 54.00% | 2.61% | 6 | -33.33% | 4 | -33.33% |
| 30 Sep, 21 | 19 | 26.67% | 7,670,788 | -3.83% | 45.48% | 2.02% | 9 | 50.00% | 6 | - |
| 30 Jun, 21 | 15 | -31.82% | 7,976,370 | -10.41% | 47.40% | 1.69% | 6 | -72.73% | 6 | - |
| 31 Mar, 21 | 22 | - | 8,903,335 | - | 52.91% | - | 22 | - | - | - |
Longboard Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Longboard Pharmaceuticals's stock was made by ARENA PHARMACEUTICALS INC on Jan 29 2024, selling 3,978,540 shares at $24.25 per share (valued at $96.48M).
Longboard Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 5 | 1 | 500.00% |
| Q2 2023 | 6 | - | - |
| Q1 2023 | 3 | - | - |
| Q2 2022 | 11 | - | - |
| Q1 2022 | 4 | - | - |
| Q4 2021 | 2 | - | - |
| Q3 2021 | 2 | - | - |
| Q1 2021 | 5 | 9 | 55.56% |
5 total buy trades, and 1 total sell trades (buy/sell ratio of 5.00%) were made by Longboard Pharmaceuticals's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | 1 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q1 2021 | - | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Longboard Pharmaceuticals's stocks.
Longboard Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| ANEB | Anebulo Pharmaceuticals, Inc. |
| DSGN | Design Therapeutics, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| TIL | Instil Bio, Inc. |
| CYT | Cyteir Therapeutics, Inc. |
| NUVB | Nuvation Bio Inc. |
| NXTC | NextCure, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| DBTX | Decibel Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| SNSE | Sensei Biotherapeutics, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| CSBR | Champions Oncology, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| GRPH | LENZ Therapeutics, Inc. |
| IKNA | Ikena Oncology, Inc. |
| MOLN | Molecular Partners AG |
| MNOV | MediciNova, Inc. |
| ASMB | Assembly Biosciences, Inc. |
| CELC | Celcuity Inc. |
| MACK | Merrimack Pharmaceuticals, Inc. |
LBPH Ownership FAQ
Who Owns Longboard Pharmaceuticals?
Longboard Pharmaceuticals is owned by institutional shareholders (170.33%), insiders (1.09%), and public (-71.42%). The largest institutional shareholder of Longboard Pharmaceuticals is FARALLON CAPITAL MANAGEMENT LLC (24.20% of total shares) and the top mutual fund owner is PRUDENTIAL SECTOR FUNDS, INC. (0.16% of total shares).
Who are the major institutional shareholders of Longboard Pharmaceuticals?
Longboard Pharmaceuticals's major institutional shareholders are FARALLON CAPITAL MANAGEMENT LLC, FMR LLC, CORMORANT ASSET MANAGEMENT, LP, RA CAPITAL MANAGEMENT, L.P., and PRICE T ROWE ASSOCIATES INC /MD/. The top five shareholders own together 80.15% of the company's share outstanding.
How many Longboard Pharmaceuticals shareholders are there?
As of Mar 2024, there are 107 institutional shareholders of Longboard Pharmaceuticals.
What percentage of Longboard Pharmaceuticals is owned by FARALLON CAPITAL MANAGEMENT LLC?
FARALLON CAPITAL MANAGEMENT LLC owns 5.79M shares of Longboard Pharmaceuticals, representing 24.20% of the company's total shares outstanding, valued at $125.07M (as of Mar 2024).
What percentage of Longboard Pharmaceuticals is owned by FMR LLC?
As of Mar 2024, FMR LLC holds 4.53M shares of Longboard Pharmaceuticals (LBPH), compromising 18.91% of the company, valued at $97.74M.
What percentage of Longboard Pharmaceuticals is owned by CORMORANT ASSET MANAGEMENT, LP?
CORMORANT ASSET MANAGEMENT, LP is the third largest holder of Longboard Pharmaceuticals. The company owns 3.35M of the company's shares outstanding (worth $72.43M).